BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12105864)

  • 1. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
    Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
    Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
    Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
    Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M
    Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Reprimo Down-regulation on Malignant Transformation of Intraductal Papillary Mucinous Neoplasm.
    Nakazato T; Suzuki Y; Tanaka R; Abe N; Masaki T; Mori T; Ohkura Y; Sugiyama M
    Pancreas; 2018 Mar; 47(3):291-295. PubMed ID: 29401170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
    Fukushima N; Walter KM; Uek T; Sato N; Matsubayashi H; Cameron JL; Hruban RH; Canto M; Yeo CJ; Goggins M
    Cancer Biol Ther; 2003; 2(1):78-83. PubMed ID: 12673124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.
    Yoshida K; Nagasaka T; Umeda Y; Tanaka T; Kimura K; Taniguchi F; Fuji T; Shigeyasu K; Mori Y; Yanai H; Yagi T; Goel A; Fujiwara T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1557-69. PubMed ID: 27095449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
    Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
    J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):280-5. PubMed ID: 16858538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.
    Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Am J Pathol; 2004 Mar; 164(3):903-14. PubMed ID: 14982844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
    Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
    Park JW; Baek IH; Kim YT
    Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
    Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
    Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
    Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M
    PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas.
    Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N
    Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
    Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
    Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
    Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.